Risk of stroke associated with nonsteroidal anti-inflammatory drugs

References

• RogerVLGoASLloyd-JonesDMAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2012 update: a report from the American Heart AssociationCirculation20121251e2e22022179539
   PubMed Web of Science ®Google Scholar
• SinghGGastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information SystemAm J Ther20007211512111319579
   PubMedGoogle Scholar
• LaineLApproaches to nonsteroidal anti-inflammatory drug use in the high-risk patientGastroenterology2001120359460611179238
   PubMed Web of Science ®Google Scholar
• BresalierRSSandlerRSQuanHAdenomatous Polyp Prevention on Vioxx (APPROVe) Trial InvestigatorsCardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trialN Engl J Med2005352111092110215713943
   PubMed Web of Science ®Google Scholar
• GreenbergJDFisherMCKremerJCORRONA InvestigatorsThe COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular riskClin Exp Rheumatol200927339540119604430
   PubMed Web of Science ®Google Scholar
• WilcoxCMCryerBTriadafilopoulosGPatterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugsJ Rheumatol200532112218222416265706
   PubMed Web of Science ®Google Scholar
• AntmanEMBennettJSDaughertyAFurbergCRobertsHTaubertKAAmerican Heart AssociationUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart AssociationCirculation2007115121634164217325246
   PubMed Web of Science ®Google Scholar
• Catella-LawsonFReillyMPKapoorSCCyclooxygenase inhibitors and the antiplatelet effects of aspirinN Engl J Med2001345251809181711752357
   PubMed Web of Science ®Google Scholar
• WarnerTDMitchellJACyclooxygenases: new forms, new inhibitors, and lessons from the clinicFASEB J200418779080415117884
   PubMed Web of Science ®Google Scholar
• CryerBFeldmanMCyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugsAm J Med199810454134219626023
   PubMed Web of Science ®Google Scholar
• SmithSCBenjaminEJBonowROAHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses AssociationJ Am Coll Cardiol201158232432244622055990
   PubMed Web of Science ®Google Scholar
• FosslienECardiovascular complications of non-steroidal anti-inflammatory drugsAnn Clin Lab Sci200535434738516254252
   PubMed Web of Science ®Google Scholar
• Catella-LawsonFCroffordLJCyclooxygenase inhibition and thrombogenicityAm J Med2001110Suppl 3AS28S32
   PubMedGoogle Scholar
• KnightsKMMangoniAAMinersJODefining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicityExpert Rev Clin Pharmacol20103676977622111779
   PubMed Web of Science ®Google Scholar
• KirkbyNSLundbergMHHarringtonLSCyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular systemProc Natl Acad Sci USA201210943175971760223045674
   PubMed Web of Science ®Google Scholar
• MangoniAACrillyMAKnightsKMCardiovascular toxicity of nonsteroidal anti-inflammatory drugs: moving beyond cyclooxygenase selectivityExpert Rev Clin Pharmacol20114329930222114775
   PubMedGoogle Scholar
• BowmanTSGazianoJMKaseCSSessoHDKurthTBlood pressure measures and risk of total, ischemic, and hemorrhagic stroke in menNeurology200667582082316966544
   PubMed Web of Science ®Google Scholar
• ADAPT Research GroupCardiovascular and cerebrovascular events in the randomized, controlled Alzheimer’s Disease Anti-Inflammatory Prevention Trial (ADAPT)PLoS Clin Trials200617e3317111043
   PubMedGoogle Scholar
• AisenPSSchaferKAGrundmanMAlzheimer’s Disease Cooperative StudyEffects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trialJAMA2003289212819282612783912
   PubMed Web of Science ®Google Scholar
• CollantesECurtisSPLeeKWEtoricoxib Rheumatoid Arthritis Study GroupA multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]BMC Fam Pract200231012033987
   PubMedGoogle Scholar
• GeusensPAltenRRovenskyJEfficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritisInt J Clin Pract200458111033104115605667
   PubMed Web of Science ®Google Scholar
• PopeJEAndersonJJFelsonDTA meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressureArch Intern Med199315344774848435027
   PubMedGoogle Scholar
• SinghGFortJGGoldsteinJLSUCCESS-I InvestigatorsCelecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I StudyAm J Med2006119325526616490472
   PubMed Web of Science ®Google Scholar
• SowersJRWhiteWBPittBCelecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) InvestigatorsThe Effects of cyclooxygenase-2 inhibitors and nonsteroidal antiinflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitusArch Intern Med2005165216116815668361
   PubMed Web of Science ®Google Scholar
• JohnsonAGNguyenTVDayRODo nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysisAnn Intern Med199412142893008037411
   PubMed Web of Science ®Google Scholar
• BavryAAKhaliqAGongYHandbergEMCooper-DehoffRMPepineCJHarmful effects of NSAIDs among patients with hypertension and coronary artery diseaseAm J Med2011124761462021596367
   PubMed Web of Science ®Google Scholar
• SolomonSDMcMurrayJJPfefferMAAdenoma Prevention with Celecoxib (APC) Study InvestigatorsCardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionN Engl J Med2005352111071108015713944
   PubMed Web of Science ®Google Scholar
• SilversteinFEFaichGGoldsteinJLGastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyJAMA2000284101247125510979111
   PubMed Web of Science ®Google Scholar
• BombardierCLaineLReicinAVIGOR Study GroupComparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupN Engl J Med2000343211520152811087881
   PubMed Web of Science ®Google Scholar
• BakSAndersenMTsiropoulosIRisk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control studyStroke200334237938612574546
   PubMed Web of Science ®Google Scholar
• AbrahamNSEl-SeragHBHartmanCRichardsonPDeswalACyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accidentAliment Pharmacol Ther200725891392417402995
   PubMed Web of Science ®Google Scholar
• AndersohnFSchadeRSuissaSGarbeECyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control studyStroke20063771725173016728684
   PubMed Web of Science ®Google Scholar
• SolomonDHAvornJStürmerTGlynnRJMogunHSchneeweissSCardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of riskArthritis Rheum20065451378138916645966
   PubMed Web of Science ®Google Scholar
• RoumieCLMitchelEFKaltenbachLArbogastPGGideonPGriffinMRNonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for strokeStroke20083972037204518436878
   PubMed Web of Science ®Google Scholar
• HaagMDBosMJHofmanAKoudstaalPJBretelerMMStrickerBHCyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of strokeArch Intern Med2008168111219122418541831
   PubMed Web of Science ®Google Scholar
• TrelleSReichenbachSWandelSCardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysisBMJ2011342c708621224324
   PubMed Web of Science ®Google Scholar
• BhalaNEmbersonJMerhiACoxib and traditional NSAID Trialists’ (CNT) CollaborationVascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsLancet2013382989476977923726390
   PubMed Web of Science ®Google Scholar
• ChenLCAshcroftDMDo selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trialsJ Clin Pharm Ther200631656557617176361
   PubMed Web of Science ®Google Scholar
• Varas-LorenzoCRiera-GuardiaNCalingaertBStroke risk and NSAIDs: a systematic review of observational studiesPharmacoepidemiol Drug Saf201120121225123621971833
   PubMed Web of Science ®Google Scholar
• JohnsenSPPedersenLFriisSNonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control studyStroke200334238739112574547
   PubMed Web of Science ®Google Scholar
• ChoiNKParkBJJeongSWYuKHYoonBWNonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis studyStroke200839384584918258834
   PubMed Web of Science ®Google Scholar
• LeeTABartleBWeissKBImpact of NSAIDS on mortality and the effect of preexisting coronary artery disease in US veteransAm J Med2007120198. e9e1617208086
   PubMed Web of Science ®Google Scholar
• CaponeMLTacconelliSSciulliMGClinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjectsCirculation2004109121468147115037526
   PubMed Web of Science ®Google Scholar
• KearneyPMBaigentCGodwinJHallsHEmbersonJRPatronoCDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ200633275531302130816740558
   PubMed Web of Science ®Google Scholar
• CullenDJSeagerJMHolmesSPharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practicesAliment Pharmacol Ther200014217718510651658
   PubMed Web of Science ®Google Scholar
• LanasAFerrandezAInappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderlyDrugs Aging200724212113117313200
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc20095781331134619573219
   PubMed Web of Science ®Google Scholar
• WheltonAFortJGPumaJANormandinDBelloAEVerburgKMSUCCESS VI Study GroupCyclooxygenase-2 – specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patientsAm J Ther200182859511304662
   PubMedGoogle Scholar
• WheltonAWhiteWBBelloAEPumaJAFortJGSUCCESS-VII InvestigatorsEffects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritisAm J Cardiol200290995996312398962
   PubMed Web of Science ®Google Scholar
• MangoniAAWoodmanRJGilbertALKnightsKMUse of nonsteroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran communityPharmacoepidemiol Drug Saf201019549049820437458
   PubMed Web of Science ®Google Scholar
• SeshadriSBeiserAKelly-HayesMThe lifetime risk of stroke: estimates from the Framingham StudyStroke200637234535016397184
   PubMed Web of Science ®Google Scholar
• ReevesMJBushnellCDHowardGSex differences in stroke: epidemiology, clinical presentation, medical care, and outcomesLancet Neurol200871091592618722812
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task ForceAspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recommendation statementAnn Intern Med200915039640419293072
   PubMed Web of Science ®Google Scholar
• BeckerMCWangTHWisniewskiLPRECISION InvestigatorsRationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritisAm Heart J2009157460661219332185
   PubMed Web of Science ®Google Scholar
• MacdonaldTMMackenzieISWeiLHawkeyCJFordISCOT study group collaboratorsMethodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)BMJ Open201331e002295
   PubMed Web of Science ®Google Scholar